Effects of Pergolide on Sensorimotor Gating of the Startle Reflex in Rats
Overview
Affiliations
Rationale: Prepulse inhibition (PPI), a cross-species measure of sensorimotor gating, is impaired in certain neuropsychiatric disorders, including schizophrenia. This study was designed to assess the effects of the D2-family agonist pergolide in rats, in anticipation of human studies of the dopaminergic regulation of PPI.
Methods: The effects of pergolide (0.0001-0.5 mg/kg) on PPI of the acoustic startle reflex were studied in rats using a wide range of prepulse intensities [1-15 dB(A) over background] and prepulse intervals (5-100 ms, onset to onset). Studies also examined the effects of the D2 antagonist haloperidol on pergolide-induced changes in PPI.
Results: Pergolide exhibited dose- and stimulus-dependent effects on PPI. Pergolide increased PPI when startle stimuli were preceded by weak prepulses [1-5 dB(A) over background] at the longest prepulse interval (100 ms), or intense prepulses [15 dB(A) over background] at short prepulse intervals (5-20 ms). Pergolide (0.5 mg/kg) also decreased PPI elicited by intense prepulses at long intervals (60-100 ms). Both PPI-enhancing and PPI-disruptive effects of pergolide were reversed by the D2 antagonist haloperidol.
Conclusions: These effects of pergolide suggest that D2 substrates mediate opposing influences on PPI under different stimulus conditions. The dopaminergic regulation of sensorimotor gating appears to interact with stimulus characteristics such as relative intensity and temporal separation, allowing for dynamic shifts in both the quantity and quality of "gated" information.
Waguespack H, Maior R, Campos-Rodriguez C, Jacobs J, Malkova L, Forcelli P Neuropharmacology. 2023; 235:109563.
PMID: 37116610 PMC: 10461600. DOI: 10.1016/j.neuropharm.2023.109563.
Sensory Gating in Neurodevelopmental Disorders: A Scoping Review.
Schulz S, Luszawski M, Hannah K, Stevenson R Res Child Adolesc Psychopathol. 2023; 51(7):1005-1019.
PMID: 37014483 DOI: 10.1007/s10802-023-01058-9.
Effect of apomorphine on cognitive performance and sensorimotor gating in humans.
Schellekens A, Grootens K, Neef C, Movig K, Buitelaar J, Ellenbroek B Psychopharmacology (Berl). 2009; 207(4):559-69.
PMID: 19834690 PMC: 2784073. DOI: 10.1007/s00213-009-1686-1.
Mizoguchi H, Arai S, Koike H, Ibi D, Kamei H, Nabeshima T Psychopharmacology (Berl). 2009; 207(2):235-43.
PMID: 19756526 DOI: 10.1007/s00213-009-1651-z.
Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice.
Flood D, Choinski M, Marino M, Gasior M Psychopharmacology (Berl). 2009; 205(3):369-77.
PMID: 19404613 DOI: 10.1007/s00213-009-1547-y.